Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms

American Journal of Hematology

Volumn 89, Issue 12, 2014, Pages 1107-1110

  Jäger, Roland ^a   Harutyunyan, Ashot S ^a   Rumi, Elisa ^b,c   Pietra, Daniela ^b   Berg, Tiina ^a   Olcaydu, Damla ^a   Houlston, Richard S ^d   Cazzola, Mario ^b,c   Kralovics, Robert ^a,e  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; TELOMERASE REVERSE TRANSCRIPTASE; JAK2 PROTEIN, HUMAN; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; COHORT ANALYSIS; FAMILIAL DISEASE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GERMLINE MUTATION; HAPLOTYPE; HERITABILITY; HUMAN; MYELOPROLIFERATIVE NEOPLASM; PATHOGENESIS; PRIORITY JOURNAL; SOMATIC MUTATION; ADULT; GENETICS; HEMATOLOGIC NEOPLASMS; ITALY; MALE; MIDDLE AGED; MULTIGENE FAMILY; MYELOPROLIFERATIVE DISORDERS; PATHOLOGY; PEDIGREE; PENETRANCE; RISK;

ADULT; COHORT STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HAPLOTYPES; HEMATOLOGIC NEOPLASMS; HUMANS; ITALY; JANUS KINASE 2; MALE; MIDDLE AGED; MULTIGENE FAMILY; MYELOPROLIFERATIVE DISORDERS; PEDIGREE; PENETRANCE; RISK; TELOMERASE;

EID: 84939127342     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23842     Document Type: Article

References (30)

1. Cazzola M, Kralovics R. From Janus kinase 2 to calreticulin: The clinically relevant genomic landscape of myeloproliferative neoplasms. Blood 2014;123:3714-3719.
2. Kralovics R, Passamonti F, Buser A, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352:1779-1790.
3. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-1061.
4. Levine RL, Loriaux M, Huntly BJ, et al. The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood 2005;106:3377-3379.
5. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005;434:1144-1148.
6. Beer PA, Campbell PJ, Scott LM, et al. MPL mutations in myeloproliferative disorders: Analysis of the PT-1 cohort. Blood 2008;112:141-149.
7. Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013;369:2379-2390.
8. Nangalia J, Massie CE, Baxter EJ, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 2013;369:2391-2405.
9. Rumi E, Passamonti F, Della Porta MG, et al. Familial chronic myeloproliferative disorders: Clinical phenotype and evidence of disease anticipation. J Clin Oncol 2007;25:5630-5635.
10. Harutyunyan AS, Kralovics R. Role of germline genetic factors in MPN pathogenesis. Hematol Oncol Clin North Am 2012;26:1037-1051.
11. Rumi E, Harutyunyan AS, Pietra D, et al. CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis. Blood 2014;123:2416-2419.
12. Olcaydu D, Harutyunyan A, Jäger R, et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet 2009;41:450-454.
13. Jones AV, Chase A, Silver RT, et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 2009;41:446-449.
14. Kilpivaara O, Mukherjee S, Schram AM, et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet 2009;41:455-459.
15. Olcaydu D, Rumi E, Harutyunyan A, et al. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms. Haematologica 2010;96:367-374.
16. Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 2010;10:353-361.
17. Oddsson A, Kristinsson SY, Helgason H, et al. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms. Leukemia 2014;28:1371-1374.
18. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: Foundation for Statistical Computing; 2013.
19. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet 2008;40:1204-1210.
20. Lubbe SJ, Di Bernardo MC, Broderick P, et al. Comprehensive evaluation of the impact of 14 genetic variants on colorectal cancer phenotype and risk. Am J Epidemiol 2012;175:1-10.
21. Landgren O, Goldin LR, Kristinsson SY, et al. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24, 577 first-degree relatives of 11, 039 patients with myeloproliferative neoplasms in Sweden. Blood 2008;112:2199-2204.
22. Bojesen SE. Telomeres and human health. J Intern Med 2013;274:399-413.
23. Bojesen SE, Pooley KA, Johnatty SE, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013;45:371-384, 384e1-384e2.
24. Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013;45:422-427, 427e1-427e2.
25. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-1406.
26. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008;40:1407-1409.
27. Gago-Dominguez M, Jiang X, Conti DV, et al. Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: Findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis 2011;32:197-202.
28. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41:899-904.
29. Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010;42:210-215.
30. Houlston RS, Peto J. The future of association studies of common cancers. Human Genet 2003;112:434-435.